Furler, Michelle D <br/><br/>
Cost impact of switching histamine(2)-receptor antagonists to nonprescription status.  [electronic resource] 

 -  The Annals of pharmacotherapy   
 - 1135-41 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1060-0280 
<br/><br/><label>Standard No.: </label>10.1345/aph.1A231  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Canada<br/>Gastrointestinal Agents--administration & dosage<br/>Histamine H2 Antagonists--administration & dosage<br/>Humans<br/>Nonprescription Drugs--administration & dosage<br/>Pharmacoepidemiology<br/>United Kingdom<br/>United States